Pfizer
BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | Pharmaceuticals
 |
Yearly Results of Pfizer |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Nov '04 | Nov '05 | Nov '06 | Nov '07 | Nov '08 | ||||||
|
||||||||||
| Sales Turnover | 557.78 | 598.52 | 662.35 | 672.66 | 700.61 | |||||
| Other Income | 39.24 | 41.03 | 59.40 | 342.70 | 70.52 | |||||
| Total Income | 597.02 | 639.55 | 721.75 | 1,015.36 | 771.13 | |||||
| Total Expenses | 491.89 | 492.94 | 523.23 | 539.82 | 549.35 | |||||
| Operating Profit | 65.89 | 105.58 | 139.12 | 132.84 | 151.26 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -19.22 | -23.37 | -23.37 | -17.35 | 207.90 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 105.13 | 146.61 | 198.52 | 475.54 | 221.78 | |||||
| Interest | 0.81 | 0.15 | 0.07 | 0.02 | -- | |||||
| PBDT | 85.10 | 123.09 | 175.08 | 458.17 | 429.68 | |||||
| Depreciation | 10.26 | 13.85 | 13.07 | 8.04 | 11.12 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 74.84 | 109.24 | 162.01 | 450.13 | 418.56 | |||||
| Tax | 29.32 | 41.12 | 56.28 | 111.21 | 119.44 | |||||
| Net Profit | 45.52 | 68.12 | 105.73 | 338.92 | 299.12 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 15.81 | 22.83 | 35.43 | 113.58 | 100.24 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 28.80 | 29.84 | 29.84 | 29.84 | 29.84 | |||||
| Reserves | 312.92 | 346.72 | 409.91 | -- | 869.73 | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Pfizer connections | ||||||||||
| ||||||||||
